3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
2
Phase 2
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
2
Conditions
Breast Neoplasms
2
Osteoporotic Fractures
1
Osteoporosis
1
Neoplastic Cells, Circulating
1
Neoplasm Metastasis
1
Musculoskeletal Pain
1
Arthralgia
1
Interventions
Letrozole
23
Docetaxel
17
Cyclophosphamide
13
Zoledronic Acid
12
Trastuzumab
12
Anastrozole
12
exemestane
11
Tamoxifen
11
Paclitaxel
11
Capecitabine
10
Fulvestrant
8
Epirubicin
8
pegfilgrastim
7
Saline Solution
7
Bupivacaine
7
pertuzumab
6
liposomal doxorubicin
6
abemaciclib
6
Sodium Chloride
6
Filgrastim
6
Carboplatin
6
pegylated granulocyte colony-stimulating factor
5
palbociclib
5
Ropivacaine
5
Dexmedetomidine
5
Bevacizumab
5
ribociclib
4
eribulin
4
Vinorelbine
4
Tranexamic Acid
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 4
×
Diphosphonates
×
Breast
×
Clear all
NCT03811509
2019-01-28
B-ABLE
Parc de Salut Mar
Phase 4
Unknown
1,000 enrolled
NCT01129336
2014-05-20
MACS1295
Novartis
Phase 4
Completed
44 enrolled
10 charts